Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review. The proportion of commercially sponsored clinical ...

GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales in the first quarter of ...

The intense campaign of airstrikes in Yemen under Donald Trump, targeting the rebels over their attacks on shipping in Mideast waters stemming from the Israel-Hamas war, has killed 67 people ...